Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2003 December;55(4) > Minerva Urologica e Nefrologica 2003 December;55(4):205-18

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,984


eTOC

 

REVIEWS  


Minerva Urologica e Nefrologica 2003 December;55(4):205-18

Copyright © 2003 EDIZIONI MINERVA MEDICA

language: English

Prostate biopsy

Seitz C., Palermo S., Djavan B.

Department of Urology University of Vienna, Vienna, Austria


PDF  


Trans­rec­tal ultra­sound guid­ed (­TRUS) pros­tate biop­sies is the stan­dard meth­od in the diag­no­sis of pros­tate can­cer. The use of pros­tate spe­cif­ic anti­gen (PSA) and dig­i­tal rec­tal exam­ina­tion for pros­tate can­cer screen­ing has led to a dra­mat­ic ­increase in the num­ber of ­TRUS guid­ed biop­sies. Fre­quent­ly urol­o­gists are ­faced ­with the dilem­ma of treat­ing a ­patient ­with a ­high sus­pi­cion of pros­tate can­cer, but an ­initial set of neg­a­tive biop­sies. In ­this ­review we ­focus on the cur­rent knowl­edge of pros­tate biop­sies, the indi­ca­tion to per­form a biop­sy, the ­impact of pros­tate vol­ume in the num­ber of ­cores tak­en, the tech­nique of an ­initial and ­repeat biop­sies and ­when to ­stop.

top of page

Publication History

Cite this article as

Corresponding author e-mail